Home » Topics » BioWorld

BioWorld
RSS

REPLIGEN-LILLY DEAL WORTH MORE THAN $14M

May 19, 1992

XYTRONYX RAISES $3.2 MILLION

May 19, 1992

PHASE I RESPONSES TO FUSION TOXIN

May 19, 1992

MONDAY STOCKS

May 19, 1992

LIPID DELIVERY FOR MENINGITIS

May 19, 1992

BIOMATRIX DEAL WITH QUEBEC GOVERNMENT

May 19, 1992

HOW COLLAGEN FACED CONTROVERSY

May 18, 1992

FRIDAY'S STOCKS

May 18, 1992

APPOINTMENTS AND ADVANCEMENTS

May 18, 1992

SILENCE MAY NOT BE GOLDEN

May 18, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...